Effect of Transcutaneous Electrical Stimulation on Post-stroke Dysphagic Patients
Launched by HOSPITAL DE MATARÓ · Jun 1, 2011
Trial Information
Current as of June 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18
- • Background of swallowing difficulties associated with stroke, more than 3 months of evolution
- • Study explained and signed informed consent
- Exclusion Criteria:
- • Patients who are suspected or can not meet the protocol. patients who are participating or have participated in a trial last 4 weeks. Patients with active cancer Patients with active infectious process. patients with severe dementia or inability to communicate. patients with neurodegenerative diseases. patients with pacemakers. patients with implanted electrodes. patients with epilepsy or seizure disorders. patients with gastroesophageal reflux.
About Hospital De Mataró
Hospital de Mataró is a leading healthcare institution located in Mataró, Spain, dedicated to advancing medical research and improving patient care through clinical trials. As a prominent sponsor of clinical studies, the hospital fosters innovative research initiatives that aim to evaluate new treatments and therapies across various medical fields. With a commitment to ethical standards and patient safety, Hospital de Mataró collaborates with multidisciplinary teams of healthcare professionals and researchers to contribute to the global body of medical knowledge while enhancing the health outcomes of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mataró, Barcelona, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials